Home Cart Sign in  
Chemical Structure| 934240-31-0 Chemical Structure| 934240-31-0

Structure of Raxatrigine HCl
CAS No.: 934240-31-0

Chemical Structure| 934240-31-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CNV1014802 HCl is a blocker of Nav1.7 sodium channel with analgesic effects.

Synonyms: GSK-1014802 hydrochloride; Vixotrigine hydrochloride; Vixotrigine

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Raxatrigine HCl

CAS No. :934240-31-0
Formula : C18H20ClFN2O2
M.W : 350.82
SMILES Code : O=C([C@H]1N[C@@H](C2=CC=C(OCC3=CC=CC=C3F)C=C2)CC1)N.[H]Cl
Synonyms :
GSK-1014802 hydrochloride; Vixotrigine hydrochloride; Vixotrigine
MDL No. :MFCD28900694
InChI Key :HEPUBAGOKRIZEO-PPPUBMIESA-N
Pubchem ID :16046067

Safety of Raxatrigine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02551497 Healthy PHASE1 COMPLETED 2016-08-26 Research Site, Nottingham, Uni... More >>ted Kingdom Less <<
NCT02751905 Neuropathic Pain PHASE1 COMPLETED 2025-05-16 Research Site, Madison, Wiscon... More >>sin, 53704, United States Less <<
NCT02957617 Neuropathic Pain From Lumbosac... More >>ral Radiculopathy Less << PHASE2 TERMINATED 2019-02-07 Research Site, Klagenfurt, 902... More >>0, Austria|Research Site, Leuven, 3212, Belgium|Research Site, Blagoevgrad, 2700, Bulgaria|Research Site, Ruse, 7003, Bulgaria|Research Site, Sofia, 1000, Bulgaria|Research Site, Sofia, 1431, Bulgaria|Research Site, Sofia, 1784, Bulgaria|Research Site, Sofia, 4001, Bulgaria|Research Site, Veliko Tarnovo, 5000, Bulgaria|Research Site, Beroun, 26601, Czechia|Research Site, Chocen, 56501, Czechia|Research Site, Litomerice, 41201, Czechia|Research Site, Litomysl, 57001, Czechia|Research Site, Ostrava, 70200, Czechia|Research Site, Prachatice, 38301, Czechia|Research Site, Prague, 10000, Czechia|Research Site, Prague, 14000, Czechia|Research Site, Prague, 16000, Czechia|Research Site, Prague, 179012, Czechia|Research Site, Zlin, 76001, Czechia|Research Site, Tartu, 51014, Estonia|Research Site, Paris, 75014, France|Research Site, Tbilisi, 0144, Georgia|Research Site, Tbilisi, 0160, Georgia|Research Site, Tbilisi, 0179, Georgia|Research Site, Tbilisi, 0186, Georgia|Research Site, Rome, 00161, Italy|Research Site, Liepaja, LV-3414, Latvia|Research Site, Riga, LV-1002, Latvia|Research Site, Riga, LV-1003, Latvia|Research Site, Bucharest, 010584, Romania|Research Site, Cluj-Napoca, 400437, Romania|Research Site, Craiova, 200642, Romania|Research Site 1, Belgrade, 11000, Serbia|Research Site 2, Belgrade, 11000, Serbia|Research Site, Belgrade, 21000, Serbia|Research Site, Banska Bystrica, 974 04, Slovakia|Research Site, Dubnica nad Vahom, 018 41, Slovakia|Research Site, Krompachy, 053 42, Slovakia|Research Site, Pruske, 01852, Slovakia|Research Site, Spisska Nova Ves, 052 01, Slovakia|Research Site, Barcelona, 08907, Spain|Research Site, Granada, 18014, Spain|Research Site, Madrid, 28040, Spain|Research Site, Madrid, 28046, Spain|Research Site, Madrid, 28690, Spain|Research Site, Madrid, 28938, Spain|Research Site, Edinburgh, EH4 2XU, United Kingdom|Research Site, Liverpool, L9 7LI, United Kingdom|Research Site, London, NW3 2QG, United Kingdom|Research Site, London, SE1 7EH, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.29mL

14.25mL

2.85mL

1.43mL

28.50mL

5.70mL

2.85mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories